🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to explore the effectiveness and safety ...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-03-01
Trial ID
NCT05596708
Treatments Being Tested
This study is designed to explore the efficacy and safety of Telitacicept c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06723548
Treatments Being Tested
A study to evaluate efficacy and safety of telitacicept in the treatment of...
Status
Recruiting
Location
Ruijin Hospital
Start Date
2024-12-06
Trial ID
NCT06654596
Treatments Being Tested
This is a multi-center, open-label, phase I study....
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-05-11
Trial ID
NCT05247203
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Telitac...
Status
Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2023-04-17
Trial ID
NCT05680480
Treatments Being Tested
To observe the safety and effectivity of a Recombinant Human B Lymphocyte S...
Status
Terminated
Location
the Third Affiliated Hospital,Sun Yat-Sen University
Start Date
2021-05-13
Trial ID
NCT04625153
Treatments Being Tested
The main objective is to explore the efficacy and safety of Telitacicept in...
Status
Recruiting
Location
Beijing Tongren Hospital,Capital Medical University
Start Date
2024-12-01
Trial ID
NCT06510283
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy of Telitacicept...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-02
Trial ID
NCT07355257
Treatments Being Tested
This is a Phase 2, multi-center, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Remegen Site #5
Start Date
2021-11-04
Trial ID
NCT04905212
Treatments Being Tested